|
Delayed
Swiss Exchange
14:18:28 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.0212 CHF | +2.91% |
|
-6.19% | -61.73% |
| 10-08 | Swiss Market Index Retreats; Novartis Shares Decline | MT |
| 10-08 | Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.91% | -6.19% | +2.91% | -47.78% | -61.73% | -67.28% | -56.91% | -98.20% | -99.11% | 3.18M | |
| -0.62% | +0.50% | -11.61% | +12.26% | +56.67% | +33.92% | +60.07% | +2.90% | - | 64.38B | |
| +0.87% | +3.73% | -4.18% | +8.68% | +13.20% | +15.52% | +85.51% | +206.77% | +5,695.71% | 56.16B | |
| +0.44% | +1.71% | +11.72% | +12.70% | +19.49% | +15.08% | +106.29% | -15.80% | +244.00% | 54.16B | |
| -3.08% | -4.32% | -0.58% | +12.40% | +18.58% | +23.47% | +50.87% | +3.24% | +272.57% | 45.33B | |
| +0.24% | -1.31% | +1.84% | +15.71% | +22.67% | +20.91% | +99.71% | +4.26% | +1,021.16% | 42.25B | |
| -1.07% | +0.86% | -8.12% | -1.86% | +136.77% | +220.35% | +927.74% | +506.01% | - | 40.78B | |
| +3.02% | +47.39% | +66.33% | +111.33% | +92.25% | +111.85% | +95.73% | +35.83% | +248.57% | 33.8B | |
| +1.22% | -1.39% | +7.10% | +6.44% | +11.15% | +13.92% | +46.95% | +16.23% | +160.92% | 32.25B | |
| -1.29% | -1.72% | -16.86% | +12.95% | +41.48% | +21.00% | -6.85% | -62.43% | - | 23.57B | |
| -1.13% | +0.10% | -10.27% | -5.01% | -7.35% | -15.74% | -5.42% | -67.85% | - | 22.39B | |
| +1.87% | +21.50% | -0.59% | +11.80% | -34.80% | -41.58% | +376.76% | +265.44% | +774.19% | 24.37B | |
| -3.40% | -2.04% | +5.02% | +13.35% | +16.71% | +12.95% | +171.10% | +189.52% | +2,158.82% | 18.95B | |
| -5.47% | +3.86% | +21.59% | +52.89% | +79.82% | +100.27% | +118.03% | -18.52% | +372.73% | 17.95B | |
| +0.69% | +3.52% | +16.91% | +27.81% | +40.51% | +44.64% | +87.63% | -15.37% | +111.84% | 16.88B | |
| +8.23% | +10.91% | +22.53% | +27.87% | +63.29% | +83.80% | +253.61% | +229.82% | +575.83% | 16.4B | |
| -0.55% | +3.59% | +10.66% | +0.41% | - | - | - | - | - | 16.62B | |
| -2.46% | +13.87% | +24.11% | +27.45% | +15.78% | +27.61% | -11.41% | -26.98% | +162.79% | 16.14B | |
| -4.03% | +2.59% | -0.42% | +10.19% | +180.86% | +166.14% | +341.90% | +1,407.09% | +787.81% | 15.77B | |
| -6.95% | +7.34% | -11.38% | +63.87% | +22.91% | -15.87% | - | - | - | 14.05B | |
| Average | -0.51% | +5.78% | +6.33% | +18.67% | +38.33% | +40.58% | +152.29% | +142.33% | +891.99% | 28.61B | |
| Weighted average by Cap. | -0.40% | +5.03% | +4.79% | +19.58% | +41.70% | +45.32% | +163.67% | +121.21% | +1,267.98% |
- Stock Market
- Stocks
- ADXN Stock
- Sector Addex Therapeutics Ltd
Select your edition
All financial news and data tailored to specific country editions
